MoonLake Immunotherapeutics's total assets for Q2 2025 were $460.10M, a decrease of -10.01% from the previous quarter. MLTX total liabilities were $102.15M for the fiscal quarter, a 3.52% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.